Copyright 2000 The New York Times Company
The New
York Times
View Related Topics
March 21, 2000, Tuesday, Late Edition - Final
SECTION: Section A; Page 22; Column
4; Editorial Desk
LENGTH: 140 words
HEADLINE: Expediting Vaccines
BODY:
To the Editor:
You are correct to
note that drug companies need special incentives to develop vaccines for
diseases that primarily affect the world's poorest countries (editorial, March
14). While the Clinton administration's proposal to provide targeted tax credits
on the sales of new vaccines will help, more needs to be done to fully engage
the drug and biotech industries.
The Vaccines for the New Millennium Act
incorporates the president's proposal and would also provide public venture
capital and transferable tax credit for research and
development into AIDS, tuberculosis and malaria vaccines. It would also
create a multilateral fund to buy these vaccines and distribute them in the
world's poorest countries.
SETH BERKLEY, M.D.
President,
International
AIDS Vaccine Initiative
New York, March
14, 2000
http://www.nytimes.com
LOAD-DATE: March 21, 2000 
